Literature DB >> 17205537

Characterization of a 3;6 translocation associated with renal cell carcinoma.

Rebecca E Foster1, Mahera Abdulrahman, Mark R Morris, Elena Prigmore, Susan Gribble, Beeling Ng, Dean Gentle, Steven Ready, Phil M T Weston, Michael S Wiesener, Takeshi Kishida, Masahiro Yao, Val Davison, Jose Luis Barbero, Carol Chu, Nigel P Carter, Farida Latif, Eamonn R Maher.   

Abstract

The most frequent cause of familial clear cell renal cell carcinoma (RCC) is von Hippel-Lindau disease and the VHL tumor suppressor gene (TSG) is inactivated in most sporadic clear cell RCC. Although there is relatively little information on the mechanisms of tumorigenesis of clear cell RCC without VHL inactivation, a subset of familial cases harbors a balanced constitutional chromosome 3 translocation. To date nine different chromosome 3 translocations have been associated with familial or multicentric clear cell RCC; and in three cases chromosome 6 was also involved. To identify candidate genes for renal tumorigenesis we characterized a constitutional translocation, t(3;6)(q22;q16.1) associated with multicentric RCC without evidence of VHL target gene dysregulation. Analysis of breakpoint sequences revealed a 1.3-kb deletion on chromosome 6 within the intron of a 2 exon predicted gene (NT_007299.434). However, RT-PCR analysis failed to detect the expression of this gene in lymphoblast, fibroblast, or kidney tumor cell lines. No known genes were disrupted by the translocation breakpoints but several candidate TSGs (e.g., EPHB1, EPHA7, PPP2R3A RNF184, and STAG1) map within close proximity to the breakpoints. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17205537      PMCID: PMC2695133          DOI: 10.1002/gcc.20403

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  45 in total

1.  Multifocal renal cancer associated with renal artery aneurysm and a unique genetic change.

Authors:  K Subramonian; P M Weston; P Curley
Journal:  Br J Urol       Date:  1998-11

2.  Identification of genes induced by BRCA1 in breast cancer cells.

Authors:  Arzu Atalay; Tim Crook; Mehmet Ozturk; Isik G Yulug
Journal:  Biochem Biophys Res Commun       Date:  2002-12-20       Impact factor: 3.575

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

Review 4.  FHIT as tumor suppressor: mechanisms and therapeutic opportunities.

Authors:  Yuri Pekarsky; Alexey Palamarchuk; Kay Huebner; Carlo M Croce
Journal:  Cancer Biol Ther       Date:  2002 May-Jun       Impact factor: 4.742

Review 5.  The role of ephrins and Eph receptors in cancer.

Authors:  Hanna Surawska; Patrick C Ma; Ravi Salgia
Journal:  Cytokine Growth Factor Rev       Date:  2004-12       Impact factor: 7.638

Review 6.  Von Hippel-Lindau disease.

Authors:  Eamonn R Maher
Journal:  Curr Mol Med       Date:  2004-12       Impact factor: 2.222

7.  HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

Authors:  Stefano J Mandriota; Kevin J Turner; David R Davies; Paul G Murray; Neil V Morgan; Heidi M Sowter; Charles C Wykoff; Eamonn R Maher; Adrian L Harris; Peter J Ratcliffe; Patrick H Maxwell
Journal:  Cancer Cell       Date:  2002-06       Impact factor: 31.743

8.  EphB1 associates with Grb7 and regulates cell migration.

Authors:  Dong Cho Han; Tang-Long Shen; Hui Miao; Bingcheng Wang; Jun-Lin Guan
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

9.  The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.

Authors:  R M Gemmill; J D West; F Boldog; N Tanaka; L J Robinson; D I Smith; F Li; H A Drabkin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).

Authors:  Bárbara Meléndez; Sandra Rodríguez-Perales; Beatriz Martínez-Delgado; Ignacio Otero; Mercedes Robledo; Angel Martínez-Ramírez; Sergio Ruiz-Llorente; Miguel Urioste; Juan Cruz Cigudosa; Javier Benítez
Journal:  Hum Genet       Date:  2002-11-13       Impact factor: 4.132

View more
  9 in total

Review 1.  Hereditary kidney cancer syndromes.

Authors:  Naomi B Haas; Katherine L Nathanson
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

2.  Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease.

Authors:  Cathy D Vocke; Christopher J Ricketts; Adam R Metwalli; Peter A Pinto; Rabindra Gautam; Mark Raffeld; Maria J Merino; Mark W Ball; W Marston Linehan
Journal:  Urology       Date:  2022-04-23       Impact factor: 2.633

3.  Array painting: a protocol for the rapid analysis of aberrant chromosomes using DNA microarrays.

Authors:  Susan M Gribble; Bee Ling Ng; Elena Prigmore; Tomas Fitzgerald; Nigel P Carter
Journal:  Nat Protoc       Date:  2009-11-05       Impact factor: 13.491

Review 4.  Hereditary kidney cancer syndromes: Genetic disorders driven by alterations in metabolism and epigenome regulation.

Authors:  Hisashi Hasumi; Masahiro Yao
Journal:  Cancer Sci       Date:  2018-02-15       Impact factor: 6.716

5.  Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms.

Authors:  Lei Chen; Yu-Hang Zhang; Zhenghua Zhang; Tao Huang; Yu-Dong Cai
Journal:  Mol Ther Methods Clin Dev       Date:  2018-06-21       Impact factor: 6.698

6.  A germline 1;3 translocation disrupting the VHL gene: a novel genetic cause for von Hippel-Lindau.

Authors:  Christopher J Ricketts; Cathy D Vocke; Martin Lang; Xiongfong Chen; Yongmei Zhao; Bao Tran; Mayank Tandon; Laura S Schmidt; Mark W Ball; W Marston Linehan
Journal:  J Med Genet       Date:  2020-10-16       Impact factor: 6.318

7.  Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma.

Authors:  Christopher Ricketts; Maurice P Zeegers; Jan Lubinski; Eamonn R Maher
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

Review 8.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

Review 9.  Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing.

Authors:  Philip S Smith; James Whitworth; Hannah West; Jacqueline Cook; Carol Gardiner; Derek H K Lim; Patrick J Morrison; R Gordon Hislop; Emily Murray; Marc Tischkowitz; Anne Y Warren; Emma R Woodward; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2020-02-05       Impact factor: 5.006

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.